NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.
Clinical trial NCT02703636 · COMPLETED
Trial details
- NCT number
- NCT02703636
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-09
- Primary completion
- 2018-05-07
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.